Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of COVID-19 Diagnostic Self-testing Using Virtual Point-of-care

NCT04348864 is registered in ClinicalTrials.gov with Neuroganics LLC as lead sponsor.

NCT NCT04348864
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04348864 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of COVID-19 Diagnostic Self-testing Using Virtual Point-of-care
Lead sponsor
Neuroganics LLC
Phase
Not applicable
Overall status
Unknown status
Start date
April 16, 2020
Completion date
April 30, 2022
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

communicable disease, coronavirus, covid-19, infectious disease, sars-cov2, virus